RBMXL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.29020002751446E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.70439999999506E-05 |
Normal-vs-Stage2 |
1.762370E-04 |
Normal-vs-Stage3 |
1.73799974412248E-10 |
Normal-vs-Stage4 |
3.66130015194699E-10 |
Stage1-vs-Stage2 |
2.088600E-01 |
Stage1-vs-Stage3 |
2.807300E-04 |
Stage1-vs-Stage4 |
2.588700E-04 |
Stage2-vs-Stage3 |
2.514000E-01 |
Stage2-vs-Stage4 |
1.521010E-01 |
Stage3-vs-Stage4 |
6.369800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.49219999689976E-08 |
Normal-vs-AfricanAmerican |
8.70150000054082E-07 |
Normal-vs-Asian |
1.758430E-01 |
Caucasian-vs-AfricanAmerican |
2.148600E-01 |
Caucasian-vs-Asian |
5.434000E-01 |
AfricanAmerican-vs-Asian |
3.005400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.22059983921031E-10 |
Normal-vs-Female |
2.01459999999987E-05 |
Male-vs-Female |
3.204000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.752100E-04 |
Normal-vs-Age(41-60Yrs) |
9.12099999972327E-07 |
Normal-vs-Age(61-80Yrs) |
1.33390000156552E-08 |
Normal-vs-Age(81-100Yrs) |
1.785390E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.855600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.597600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.536000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.519800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.273000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.855800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.870000E-01 |
Normal-vs-Grade 2 |
1.300500E-03 |
Normal-vs-Grade 3 |
5.93514126734362E-12 |
Normal-vs-Grade 4 |
7.76068098673477E-12 |
Grade 1-vs-Grade 2 |
2.965800E-01 |
Grade 1-vs-Grade 3 |
2.835600E-03 |
Grade 1-vs-Grade 4 |
2.753700E-04 |
Grade 2-vs-Grade 3 |
7.87439999982986E-07 |
Grade 2-vs-Grade 4 |
1.97300000004397E-07 |
Grade 3-vs-Grade 4 |
4.960200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.214100E-02 |
Normal-vs-ccB subtype |
1.86717308281459E-12 |
ccA subtype-vs-ccB subtype |
9.26037024839843E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.09860000044415E-07 |
Normal-vs-N1 |
3.384800E-04 |
N0-vs-N1 |
2.611800E-01 |
|
|